Immunoadjuvant compounds and uses thereof
US9061066B2 · kind B2 · utility
2Cited by
1References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 6, 2011 |
| Grant date | Jun 23, 2015 |
| Priority date | — |
| Expiry date | Jul 14, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55583
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cyclic beta glucan compounds function as an immunoadjuvant when administered prior to, concommitantly with, or subsequent to the administration of one or more antigens to a subject. These adjuvant compounds may be effectively used as dendritic cell activating molecules.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.